Business
Novo Nordisk shares jump almost 8% after US approves Wegovy pill
The approval gives the drugmaker a first-mover advantage in the race for a potent oral weight-loss medicine [COPENHAGEN/LONDON] Novo…
Tag
The approval gives the drugmaker a first-mover advantage in the race for a potent oral weight-loss medicine [COPENHAGEN/LONDON] Novo…
The week of August 18, 2025: The economics of GLP-1s, Bolivia, the economy, tariffs, and much, much more. Source link
Novo Nordisk, the Danish pharmaceutical company behind Ozempic and Wegovy, capped off a somewhat turbulent 2024, reporting profit and…